Jade Biosciences (JBIO) Gains from Investment Securities (2020 - 2025)
Jade Biosciences (JBIO) reported Gains from Investment Securities of -$735000.0 for Q4 2025, down 425.22% on a YoY basis from $226000.0 in Q4 2024, and down 244.1% quarter-over-quarter from $510051.0 in Q3 2025.
Jade Biosciences (JBIO) Gains from Investment Securities (2020 - 2025) Analysis & Trends
Jade Biosciences has reported Gains from Investment Securities for 6 years, with the latest figure at -$735000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 425.22% year-over-year to -$735000.0; the trailing twelve-month figure through Dec 2025 stood at $304000.0 (down 83.3% YoY), and the FY2025 full-year result was $9.7 million, up 306.9% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$735000.0, down from $510051.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $9.3 million in Q2 2025, with the low at -$735000.0 in Q4 2025.
- Historically, Gains from Investment Securities has averaged $2.1 million across 5 years, with a median of $1.3 million in 2023.
- The largest YoY upside for Gains from Investment Securities was 2394.35% in 2025 against a maximum downside of 425.22% in 2025.
- Jade Biosciences' Gains from Investment Securities stood at $264000.0 in 2021, then surged by 454.92% to $1.5 million in 2022, then plunged by 97.27% to $40000.0 in 2023, then soared by 465.0% to $226000.0 in 2024, then slumped by 425.22% to -$735000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$735000.0 (Q4 2025), $510051.0 (Q3 2025), and $9.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Jade Biosciences | 877.06 Mn | 877.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -735,000.00 |
| Dec 31, 2025 | -735,000.00 |
| Sep 30, 2025 | 510,051.00 |
| Sep 30, 2025 | 510,051.00 |
| Jun 30, 2025 | 9.35 Mn |
| Jun 30, 2025 | 9.35 Mn |
| Mar 31, 2025 | 773,000.00 |
| Mar 31, 2025 | 773,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Sep 30, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Mar 31, 2024 | 30,990.00 |
| Mar 31, 2024 | 30,990.00 |
| Dec 31, 2023 | 40,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Sep 30, 2023 | 5.24 Mn |
| Sep 30, 2023 | 5.24 Mn |